Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0812 | 0.3158 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0812 | 0.3158 | 0.3158 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0289 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0289 | 0 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0289 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1104 | 0.492 | 0.492 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0812 | 0.3158 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0289 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0812 | 0.3158 | 0.3158 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0812 | 0.3158 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0289 | 0 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0812 | 0.3158 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0289 | 0 | 0.5 |
Echinococcus granulosus | Lipid transport protein N terminal | 0.1104 | 0.492 | 0.492 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0812 | 0.3158 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0812 | 0.3158 | 0.3158 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0812 | 0.3158 | 0.3158 |
Leishmania major | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0812 | 0.3158 | 0.3158 |
Brugia malayi | brahma associated protein 60 kDa | 0.0812 | 0.3158 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0812 | 0.3158 | 0.3158 |
Chlamydia trachomatis | SWIB complex protein | 0.0812 | 0.3158 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0812 | 0.3158 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0289 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0812 | 0.3158 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0812 | 0.3158 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0812 | 0.3158 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.0812 | 0.3158 | 0.3158 |
Echinococcus multilocularis | microsomal triglyceride transfer protein large | 0.1946 | 1 | 1 |
Onchocerca volvulus | 0.0812 | 0.3158 | 0.6418 | |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0289 | 0 | 0.5 |
Echinococcus multilocularis | Lipid transport protein, N terminal | 0.1104 | 0.492 | 0.492 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0812 | 0.3158 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0812 | 0.3158 | 0.3158 |
Schistosoma mansoni | hypothetical protein | 0.1946 | 1 | 1 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0289 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0812 | 0.3158 | 0.3158 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0289 | 0 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0812 | 0.3158 | 0.3158 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0812 | 0.3158 | 0.3158 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0812 | 0.3158 | 0.3158 |
Loa Loa (eye worm) | hypothetical protein | 0.1946 | 1 | 1 |
Onchocerca volvulus | Apolipophorins homolog | 0.1104 | 0.492 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.512 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.485 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.461 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.448 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.327 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.038 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.952 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.633 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.